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Abstract 
 
   This study was conducted to elucidate the role of central histamine (HA) in seizure 
susceptibility.  We stimulated the left amygdala of rats to produce amygdaloid kindling.  
We sacrificed rats 1 hour, 1 week and 1 month after the last kindled seizure, and measured 
the histamine contents and the histidine decarboxylase (HDC) activities of various brain 
regions.  One hour after the last kindled seizure, we found significant decreases in HA 
levels in the bilateral amygdala, hippocampus and diencephalon in the kindled group.  
The HDC activities of the bilateral amygdala and diencephalon were lower in the kindled 
group than in the control group.  One week after the last kindled seizure, we also found a 
significant decrease in the HA level in the bilateral amygdala.  No significant change was 
found in HA content or HDC activity 1 month after the last kindled seizure.   
   These results suggest that kindling suppresses HA synthesis and that the reduced HA 
content is maintained until 1 week after the last kindled seizure.  The reduced HA may 
play a role in the acquired kindled seizure susceptibility.    
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1. Introduction 
                 
   In the central nervous system, histamine (HA) is considered as a neurotransmitter or a 
neuromodulator in the mammalian brain [3,14,16,20,25].   The cell bodies of HA neurons 
are located in the posterior hypothalamus and send nerve fibers to almost all brain regions 
[22,26].  HA is synthesized from L-histidine by histidine decarboxylase (HDC), a 
histamine synthesizing enzyme [14,16,20,27], which is located mainly in histamine 
neurons [2,26].  Central HA participates in hypothalamus functions such as sleep, 
incretion, thermo-control, and circadian rhythm [25].   
   Recently, central HA has been thought to have an anticonvulsant effect.  Tuomisto et 
al. [23,24] and Yokoyama et al. [31,32,33,36,37] indicated that central HA works as a 
seizure inhibitory factor.  It has been reported that over-dosage of anti-histamine agents 
causes convulsion, especially in children of pre-school age [1,4,12,19,28].  These clinical 
reports indicate a conceivable role for central HA in acute convulsions.  However, there is 
no report of the role of the central HA neuron system in the seizure susceptible state.   
   Repetitive subconvulsive electrical stimulation culminates in major motor seizures, a 
phenomenon called kindling [6].  And it is well known that the effect is an adequate 
model of human temporal lobe epilepsy and complex partial seizures [11,18].   
   In the present study, we investigated the role of central HA in the seizure susceptible 
brain of kindled rats.  We measured the histamine contents and the HDC activities of 
brain regions 1 hour, 1 week and 1 month after the last kindled seizure.  
 
2. Materials and methods 
  
2.1. Animals and amygdaloid kindling  
  
   Adult male rats of the Sprague-Dawley strain (Funabashi Farm Co., Funabashi, Japan), 
weighting 250-300g at the time of surgery, were used.  The rats were individually caged 
in a light- and temperature-controlled environment with water and food available ad 
libitum.     
   Before surgery, each rat was well handled.  Rats were anesthetized with pentobarbital 
sodium (50mg/kg i.p.) and were inplanted with bipolar electrodes, made of Teflon-coated 
stainless-steel wire, in the left basal amygdaloid nucleus according to the coordinates of 
Pellegrino et al. [15] (coordinates: 1 mm posterior, 4.8 mm lateral, 7.8 mm ventral from the 
bregma).  Electrode connectors were fixed by dental acrylic and anchor screws on the 
exposed skull surface.  Ground electrodes were attached to anchor screws which were 
placed on the exposed skull surface.  An equal number of rats was prepared with 
implanted electrodes in the same site but served as non-stimulated controls.  These 
control rats were only handled everyday at the time of kindling-stimulation.    
   One week after the postoperative recovery period, we determined the afterdischarge 
threshold of the left amygdala.  We stimulated using electric currents with 25μA 
increments from 50μA up to 300μA.  When afterdischarge was observed, we determined 
the threshold.  Then we stimulated rats once a day at each afterdischarge threshold.  
Stimulations from a stimulator machine (each afterdischarge, biphasic square waves 
pulses, 1 ms pulse duration, 60 cycles/s, stimulus duration of 1 s) were administrated until 
5th “stage 5” motor seizures, classified by Racine [17], were evoked.  Electrical activity of 
the amygdala was recorded on an EEG apparatus.  After completion of the kindling, we 
divided rats into 3 experimental groups for tissue preparation: 1 hour (n=6), 1 week (n=6) 
and 1 month (n=6) after last kindled seizure.   
 
2.2. Measurement of HA content 
 
   The rats were killed by decapitation.  Brains were removed rapidly and divided into 
cortex, amygdala, hippocampus, diencephalon, brain stem and cerebellum by the method 
of Glowinski and Iversen [5].  The brain tissues were stored at –80℃ until used.   
   Brain tissue was homogenized in 3% perchloric acid containing 5mM Na2 –EDTA by a 
Polytron homogenizer (Kinematica, Lucern, Switzerland) at a maximum setting for 10 s in 
ice bath, and the homogenate was centrifuged at 10,000 ×g for 10 min at 4℃ to obtain a 
clear supernatant.  The HA content was measured fluorometrically with o-phthalaldehyde 
after separation on an HPLC system as described by Yamatodani et al. [30].  Briefly, HA 
was separated on a cation exchanger, TSK gel SP2SW (Tosoh, Tokyo, Japan; particle size 5
μm) eluted with 0.25 M KH2PO4 at a flow rate of 0.6 ml/min using a constant flow pomp 
(Model CCPM, Tosoh, Tokyo, Japan).  The HA eluate was derivatized using an on-line 
automated Shore’s o –phthalaldehyde method [21], and the fluorescence intensity was 
measured at 450 nm with excitation at 360 nm in a spectrofluorometer equipped with a 
flow cell (model C-R3A, Shimadzu, Kyoto, Japan) and a chromatographic data processor 
(Model C-R3A, Shimadzu, Kyoto, Japan). 
 
2.3. Measurement of HDC activity 
 
   Brain tissue obtained as described above was homogenized in the HDC solution 
(100mM potassium phosphate buffer, pH 6.8, 0.2mM dithiothreitol, 0.01 mM pyridoxal 
5’-phosphate, 1% polyethyleneglycol and 100μg/ml phenylmethanesulfonylfluoride) in a 
Polytron homogenizer (Kinematica, Lucern, Switzerland) at a maximum setting for 10 s in 
an ice bath.  The homogenates were centrifuged at 10,000×ｇ  for 30 min and the 
supernatants were dialyzed against HDC solution overnight.  The HDC reaction was 
started at 37℃ by adding 0.5 mM L-histidine (final concentration) in a total volume of 
1.0ml.  Three hours later, the reaction was stopped by adding 0.03 ml of 60% perchloric 
acid.  The mixtures were briefly centrifuged, and the supernatants were used for HA 
analysis.  HDC activities were expressed as pmol histamine produced per min per mg of 
protein.  Proteins were determined by the method of Lowry et al. [10] with bovine serum 
albumin as standard. 
 
2.4. Statistical analysis 
 
   Statistical analysis of the data was carried out using one-way ANOVA followed by 
Duncan’s test.  In all cases, P values less than 0.05 were considered statistically 
significant. 
 
3. Results 
 
3.1. Changes of HA contents in kindled rat brains 
 
   As shown in Fig. 1, we found significant decreases of HA contents of the bilateral 
amygdala, bilateral hippocampus and diencephalon of kindled rats compared with those of 
control rats 1 hour after the last kindled seizure.   One week after the last kindled 
seizure, the histamine content of the bilateral amygdala was significantly lower than that 
of control rats (Fig.2).  There were no significant differences in HA contents between 
kindled and control rat’s brains 1 month after the last kindled seizure (data not shown). 
 
3.2. Changes in HDC activities in kindled rat brains 
 
   Table 1 shows significant decreases of HDC activities in the bilateral amygdala and 
diencephalon 1 hour after the last kindled seizure.  One week after the last kindled 
seizure, we found no significant changes in HDC activities between kindled and control 
rat’s brains (Table 2).  There were no significant changes between kindled and control 
rat’s brains 1 month after the last kindled seizure (data not shown). 
  
 
4. Discussion 
   It is well known that the activation of some neurotransmitter systems prevents 
development of kindling and induction of kindled seizure after its completion [9].  And it 
has been reported that there were some changes in regional neurotransmitter contents 
during kindling development and after completion of kindling [9].  In this paper, we 
investigated the role of central HA after the completion of kindling.     
   At first, 1 hour after the last kindled seizure, the reduced HA contents of the amygdala, 
hippocampus and diencephalon might have resulted from the suppressed HDC activity, 
mainly in the diencephalon where the HA nerve cell bodies are located.  Kindling may 
suppress HA synthesis.  These results may reflect not only the developed seizure 
susceptibility, but also the seizure itself and the effect of the electrical stimulation.          
   Secondly, in the steady state at 1 week after the last kindled seizure, restoration of the 
HDC activity to the control level indicates that the HA synthesis in the neuron may 
recover.  It is natural to find normal HA levels in the diencephalon and hippocampus.  
On the other hand, the HA content is still depressed in the bilateral amygdala.  This 
reduced HA is consistent with the report of Onodera et al. [13] that HA levels in the 
central nervous systems of genetically Epilepsy-Prone rats were lower than those of 
resistant rats.  Kairiss et al. [8] and Yamada et al. [29] reported the functional importance 
of the amygdala in the electrical rat kindling model.  The lasting HA depletion in the left 
amygdala may indicate a strong effect of the kindling on the HA system in the kindling 
foci.  This lasting HA depletion may play a role in the maintenance of high sensitivity to 
electrical re-stimulation in the kindling foci after completion of the kindling.  Goddard et 
al. [6] reported a “positive transfer effect” which means that prior kindling through one 
electrode would facilitate subsequent kindling through a second electrode located 
elsewhere in the limbic system.  They reported that the contra-lateral amygdala required 
fewer stimulations to reach a full kindled seizure following prior amygdaloid kindling.  
Therefore, this reduced histamine level of the contra-lateral amygdala 1 week after the 
last kindled seizure may partly contribute to the “positive transfer effect”.  The lasting 
HA depletion in the bilateral amygdala may suggest transient functional change of the 
central HA nervous system after acquisition of seizure susceptibility.  These results may 
reflect the seizure susceptible state obtained after kindling.  Iinuma and his colleagues 
[7,34] reported an increased histamine H1 receptor binding in epileptic foci and 
surrounding regions in patients with complex partial seizure by positron emission 
tomography.  Yokoyama et al. [35] reported that the blockade of histamine H1 receptor by 
anti-histamine agent increased the epileptic discharge in an infantile epileptic patient.  
These lines of clinical evidence, which indicate the involvement of the central HA nervous 
system in the human epileptic seizure vulnerable state, could partly support our results.  
Furthermore, Yokoyama et al. [38] reported that histamine H1 antagonists accelerate the 
development of kindling rate.  It is likely that the central HA system acts as an inhibitory 
factor to the development of brain susceptibility to the kindling stimulation.   
   We could not, however, observe any changes in HA turnover 1 month after the last 
kindled seizure.  
   In conclusion, our present study suggests that kindling reduces central HA synthesis, 
and that persisting low HA level in the amygdala until 1 week after the last kindled 
seizure may play a role in the maintenance of kindled seizure susceptibility. 
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Figure Legend 
Figure 1.  Histamine contents of brain regions of the kindled rats 1 hour after the last 
kindled seizure and of the control rats without kindling.  Results are mean and standard 
errors (n=6).  Statistical analysis was performed by one-way ANOVA followed by 
Duncan’s test. (* P<0.05 vs. the control group) 
 
Figure 2.  Histamine contents of brain regions of the kindled rats 1 week after the last 
kindled seizure and of the control rats without kindling.  Results are mean and standard 
errors (n=6).  Statistical analysis was performed by one-way ANOVA followed by Duncan’s 
test. (* P<0.05 vs. the control group) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
